反应详情

温度

90 °C

A solution of 4-chloro-6-methoxy-7-(2-(1-methylpiperidin-4-yl)ethoxy)quinazoline (300 mg, 0.9 mmol) and 4-fluoro-5-hydroxyindole (162 mg, 1 mmol), (prepared as described for the starting material in Example 242), in DMF (4.5 ml) containing potassium carbonate (185 mg, 1.3 mmol) was stirred at 90° C. for 1 hour. After cooling, the mixture was filtered and the solid was washed with DMF. The filtrate was evaporated and the residue was purified by column chromatography, eluting with methylene chloride followed by methanol/methylene chloride (1/99) followed by methanol saturated with ammonia/methylene chloride (2/98). The fractions containing the expected product were combined and evaporated. The solid was triturated with ether, filtered, washed with ether and dried under vacuum to give 4-(4-fluoroindol-5-yloxy)-6-methoxy-7-(2-(1-methylpiperidin-4-yl)ethoxy)quinazoline (282 mg, 69%).

1. temperatureAfter cooling
2. filtrationthe mixture was filtered
3. washthe solid was washed with DMF
4. customThe filtrate was evaporated
5. customthe residue was purified by column chromatography
6. washeluting with methylene chloride
7. additionThe fractions containing the expected product
8. customevaporated
9. customThe solid was triturated with ether
10. filtrationfiltered
11. washwashed with ether
12. customdried under vacuum